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Biochemical characterisation of an α1,4 galactosyltransferase 
from Neisseria weaveri for the synthesis of α1,4-linked 
galactosides  
Kun Huanga, Andrea Marchesia, Kristian Hollingsworthb, Peter Botha, Ashley P. Matteya,  
Edward Pallistera, Helene Ledruc, Simon J. Charnockd, M. Carmen Galanc, W. Bruce Turnbullb,  
Fabio Parmeggiani*,a,e, Sabine Flitsch*,a 
The human cell surface trisaccharide motifs globotriose and P1 antigen play key roles in infections by pathogenic bacteria, 
which makes them important synthetic targets as antibacterial agents. Enzymatic strategies to install the terminal α1,4-
galactosidic linkage are very attractive but have only been demonstrated for a limited set of analogues. Herein, a new 
bacterial α1,4 galactosyltransferase from N. weaveri was cloned and produced recombinantly in E. coli BL21 (DE3) cells, 
followed by investigation of its substrate specificity. We demonstrate that the enzyme can tolerate galactosamine (GalN) 
and also 6-deoxygalactose and 6-deoxy-6-fluorogalactose as donors, and lactose and N-acetyllactosamine as acceptors, 
leading directly to analogues of Gb3 and P1 that are valuable chemical probes and showcase how biocatalysis can provide 
fast access to a number of unnatural carbohydrate analogues. 
Introduction 
Carbohydrates on animal cell surfaces are often displayed as 
part of motifs that play a crucial role in biological interactions, 
such as cell-cell communication, surface recognition and 
pathogenic infection.1 Two biologically important trisaccharide 
motifs are globotriose (i.e., Gb3) and P1 antigens in which 
galactose is linked by an α1,4-glycosidic bond to lactose and N-




Figure 1. Structure of Gb3 and P1 antigen motifs on cell surface 
glycans. 
The involvement of Gb3 and P1 antigens in a number of 
biological events has been demonstrated previously, in 
particular as animal cell surface receptors for toxins and 
pathogens. Shiga-toxin produced by STEC (shiga-toxin-
producing Escherichia coli, i.e., E.coli O157) was shown to bind 
to the Gb3 motif of the glycolipid globotriosylceramide, on the 
intestinal cell surface, and this was recognised as a cause of food 
poisoning and sometimes even deadly haemolytic uremic 
syndrome (HUS).3 Similarly, Shiga-toxin recognises the P1 
antigen, which shares the same terminal Gal-α1,4-Gal epitope 
with globotriose.4 There is currently only limited therapy 
available against STEC infection and the interaction between 
globotriose and shiga-toxin provides an attractive therapeutic 
target for the development of treatments.5–9 Furthermore, the 
invasion of bacterial pathogens including Neisseria meningitidis 
and N. meningitidis immunotype L1 into mammalian cells was 
shown to be mediated by Gb3 in the bacterial 
lipooligosaccharides. 10 Therefore, Gb3 and P1 antigens, as well 
as their analogues, have been suggested as competitive 
inhibitors to prevent infections by pathogenic bacteria.5,11,12 
Since the isolation of Gb3 and P1 trisaccharides from natural 
resources is not practical, there is a need for their synthesis and 
a number of chemical routes have been reported,13–17 although 
the requirement for extensive protection/deprotection 
strategies  results in a large number of steps and in low overall 
yields.  
Enzymatic synthetic methods have also been proposed to 
access both Gb3 and P1 antigens, mainly involving α1,4 
galactosyltransferases (α1,4GalTs). Among them, NmLgtC from 
N. meningitidis is the most widely used glycosyltransferase for 
α1,4-glycosidic bond formation.18–21 Wang et al. studied the 
acceptor substrate specificity of a truncated enzyme variant 
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using UDP-galactose as the donor substrate.22 In order to 
decrease the cost of the donor substrate, coupling of the same 
system with nucleotide sugar regeneration was further 
investigated by Chen et al., to produce Gb3 antigen derivatives. 
23  Furthermore, the gene of α1,4GalT and other required 
enzymes were cloned into the same plasmid to generate a 
whole cell biocatalyst for the production of Gb3 and P1 antigens 
and their derivatives.24–26 Additionally, α1,4GalTs from 
Campylobacter jejuni 27 and Neisseria gonorrhoeae 28 were also 
cloned and used for α1,4-glycosidic bond formation.  
A limitation of enzymatic strategies is frequently a narrow 
substrate range, which can make access to analogues needed as 
biochemical probes very limited. Herein, we investigate a new 
α1,4 galactosyltransferase from N. weaveri (NwLgtC) for 
substrate promiscuity, in particular against deoxy, deoxyfluoro- 
and deoxyamino- analogues of the donor UDP-Gal. The 
applicability of this procedure to preparative scale synthesis 
was demonstrated with the preparation of a new deoxy 
derivative of Gb3 antigen (Gal6D-α1,4-Lac-pNP). 
Results and discussion 
Amino acid sequence analysis of NwLgtC 
Amino acid sequence alignment reveals that NwLgtC displays 
46% and 63% identity with NmLgtC from N. meningitidis 
(UniProt: P96945) 22 and NgLgtC from N. gonorrhoeae (UniProt: 
A0A5K1QJC7)28, respectively (Figure 2). No significant sequence 
identity was found with CgtD from C. jejuni (UniProt: 
Q8KWQ9).27 
 
Gene cloning, protein expression and purification of NwLgtC 
The open-reading frame of the LgtC gene from Neisseria 
weaveri was synthesised with codon optimisation for E. coli 
expression and subcloned into pET-28a vector with N-terminal 
His-tag. The recombinant protein was produced in E. coli BL21 
(DE3) cells using autoinduction TB medium at 25°C for 24 h. 
Protein purification was performed by Ni-NTA affinity 
chromatography, pooling all fractions containing the 
recombinant enzyme. The protein was precipitated by addition 
of ammonium sulfate (3.2 M final concentration). SDS-PAGE 
analysis (Figure 3) indicates that the recombinant enzyme 
possesses an apparent mass of approximately 35 kDa, which is 
consistent with theoretical molecular weight of 35.6 kDa. The 
specific activity against UDP-Gal and pNP-β-Lac (see assay 
conditions in the following section) was 66 mU mg–1. This value 
is significantly lower than that reported for NmLgtC (5 U mg–1) 
and NgLgtC (13 U mg–1) for the synthesis of unmodified Gb3 
antigen using UDP-Gal and lactose as donor and acceptor, 
respectively (1 U was defined as the amount of enzyme required 
for the formation of 1 µmol product per minute at 37°Ϲ).  
In view of a preparative application, the lower activity is 
certainly an issue, but not extremely critical, since activity and 
stability can be considerably improved with directed evolution 
and random mutagenesis approaches, as successfully done for 
most industrial enzymes. The most likely reasons for the lower 
activity of the NwLgtC preparation compared to reported 
homologues lie in the use of a modified substrate (pNP-β-Lac 
instead of Lac) and in the ammonium sulfate precipitation step. 






Figure 2. Amino acid sequence alignment of LgtC galactosyltransferases (NmLgtC from N. meningitidis, NgLgtC from N. 
gonorrhoeae, NwLgtC from N. weaveri, CjCgtD from C. jejuni). Highly conserved residues are shown in black. 
 
N.meningitidis  : MDIVFAADDNYAAYLCVAAKSVEAAH--PDTEIRFHVLDAGISEANRAAVAANLRGGGGNIRF :  61
N.gonorrhoeae  : MDIVFAADDNYAAYLCVAAKSVEAAH--PDTEIRFHVLDAGISEANRAAVAANLRGGG-NIRF :  60
N.weaveri    : MNIVFASDDNYASYLGVTIFSILMHN--QNAEIDFYILDLGISAESREAVSQLVGSRGCSVSF :  61
C.jejuni    : MTEISSFWYTPKGYKGIGLMEILTIKSWLDHGYKFHLYTYNLEDKIFLKFQELFDNFILKDAN :  63
N.meningitidis  : IDVNPEDFAGFPLNIRHISITTYARLKLGEYIADCDKVLYLDIDVLVRDSLTPLWDTDLGDNW : 124
N.gonorrhoeae : IDVNPEDFAGFPLNIRHISITTYARLKLGEYIADCDKVLYLDTDVLVRDGLKPLWDTDLGGNW : 123
N.weaveri    : VQVDKNDFIQMPQTIDYISIASYARLKVAEYLQDIDRALYLDVDILVTGSLQPLWETDLEGRY : 124
C.jejuni    : EIIPFEEYFSDDRGAGVAAFSDFFRFNLLYLRG----GVWVDLDMVCLN----HYDYDKKEYI : 118
N.meningitidis  : LGACIDLFVERQE-GYKQKIGMADGEYYFNAGVLLINLKKWRRHDIFKMSCEWVEQYKDVMQY : 186
N.gonorrhoeae  : VGACIDLFVERQE-GYKQKIGMADGEYYFNAGVLLINLKKWRRHDIFKMSCEWVEQYKDVMQY : 185
N.weaveri    : VGACFDPYVEFELPGYKNKIGLQEQDYYFNAGVLLMDLGKWRDYDVFAKTLAWLGGYRDVIQY : 187
C.jejuni    : FSKEIDNDLSKAR----ITTSLLKFPKQSEFGKLIIDEAKKIVDDNKIIPWGIIGPWFLAKWV : 177
N.meningitidis  : QDQDILNGLFKGGVCYANSRFNFMPTNYAFMANWFASRHTDPLYRDRTNTVMPVAVSHYCGSA : 249
N.gonorrhoeae  : QDQDILNGLFKGGVCYANSRFNFMPTNYAFMANGFASRHTDPLYLDRTNTAMPVAVSHYCGSA : 248
N.weaveri    : QDQDILNGIFKDKVKFLDCRFNFMPFERSRMKR--AKKQSGFELHPLEKATVPVVITHYCGKE : 248
C.jejuni    : KEYDLEKHALDYKDTCQISCGNTRDFIDKKIFD---KNRLCLHLFSEMWKIYKMNKNHFYKSC : 237
N.meningitidis  : KPWHRDCTAWGAERFTELGGSLTTVPEEWRGKLAVPHRMFSTKRMLQRWRRKLSARFLRKIY  : 311
N.gonorrhoeae  : KPWHRDCTVWGAERFTELAGSLTTVPEEWRGKLAVPP----TKRMLQRWRKKLSARFLRKIY  : 306
N.weaveri    : KAWHADCVHTNAYLFADIFRKLEHVPHGWTKSVCRVG----MKNRWEKIFHSIKDKYFYSIY  : 306
C.jejuni    : IYGFLLQKHNILDLCLKLNYNLSFCDKHYDKFLPFIN----IKNKIRFYFRHPKKIFKKNNA  : 295
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Figure 3. SDS-PAGE analysis of purified NwLgtC. M: protein 
marker; lane 1: purified NwLgtC.  
 
 
the loss is more than compensated by the fact that the final 
preparation can be obtained in large amounts, inexpensively 
and in a stable form (storage at 4°C, shipment at room 
temperature, etc.). 
 
Biochemical characterisation of NwLgtC 
The influence of pH, temperature and divalent metal ions on the 
activity of NwLgtC was studied by utilising pNP-β-Lac as 
acceptor. The enzymatic activity increased sharply from pH 4.5 
to 5.5, then gradually until 7.0, with a maximum around 7.0-8.0, 
and decreased for higher values (Figure 4A). This behaviour is 
comparable with its homologues NmLgtC and NgLgtC. The 
optimal temperature for the activity of NwLgtC was found to be 
around 40°Ϲ (Figure 4B), which is identical with NgLgtC. The 
activity declined significantly at temperatures higher than 40°Ϲ, 
with almost no activity left at 70°Ϲ. The presence of a divalent 
cation was confirmed to be essential for the activity of the 
recombinant enzyme. Mn2+ was the best metal ion for such 
enzyme, followed by Mg2+ and Co2+ (Figure 4C), which is in 
agreement with its characterised homologues. NwLgtC was 
inactive in the presence of Ca2+, Cu2+ or Zn2+. Furthermore, the 
activity could be improved slightly by adding DTT (data not 
 
 
shown), which has also been observed for NmLgtC.22  
A kinetic study of NwLgtC against UDP-Gal and pNP-β-Lac was 
performed, determining reaction conversions by HPLC. The 
apparent kinetic parameters were calculated by fitting the data 
to the Michaelis-Menten model using GraphPad Prism 7 (ESI, 
Figure S1). The Km for UDP-Gal and pNP-β-Lac were 0.17±0.02 
mM and 2.5±0.20 mM, and the corresponding kcat were 0.64 ± 
0.02 min–1 and 1.11 ± 0.02 min–1. Therefore, the catalytic 
efficiency values of the enzyme against UDP-Gal and pNP-β-Lac 
were 3.8 mM–1 min–1 and 0.45 mM–1 min–1, respectively. As a 
comparison, reported literature data for the homologue 
NwLgtC are: kcat = 14.2 s–1, Km = 18 μM, kcat/Km = 0.81 μM–1 s–1 
against UDP-Gal; kcat = 24.0 s–1, Km = 20 mM, kcat/Km = 1.20 mM–
1 s–1 against Lac.19 The increased efficiency reported is likely due 
to the use of the native acceptor Lac instead of the modified 
acceptor pNP-β-Lac. 
 
Donor substrate specificity study 
Initially, a panel of five commercially available nucleotide sugars 
(UDP-Gal, UDP-Glc, UDP-GalNAc, UDP-GlcNAc and UDP-GlcA) 
were tested to investigate the donor substrate specificity of 
NwLgtC, using Lac as the acceptor, under the previously 
optimised conditions. Only transfer from UDP-Gal was observed 
by MALDI-ToF analysis (ESI, Figure S12). 
In order to study substrate promiscuity in more detail, several 
nucleotide diphosphate galactose analogues 
(monodeoxygalactoses, monodeoxy-monofluorogalactoses and 
galactosamine) were synthesised by a one-pot multienzyme 
system involving galactokinase (SpGalK), galactose-1-
phosphate uridylyltransferase (EcGalPU) and UDP-sugar 
pyrophosphorylase (BlUSP), in the presence of catalytic 
amounts of UDP-Glc (Table 1). The formation of UDP-Gal and its 
analogues was confirmed by HRMS (ESI, Figures S2-S11). To 
evaluate these as donors for NwLgtC, disaccharides bearing an 
imidazolium-based tag (i.e., Lac-ITag and LacNAc-ITag) were 
utilised as acceptor substrates. These were produced by 
transferring a Gal unit by bacterial β1,4 galactosyltransferase to 
chemically synthesised Glc-ITag or GlcNAc-ITag, as previously 
reported.29 Ionic liquid tagged glycosides are excellent probes 
for the screening and characterisation of glycoenzymes, since 
they ionise very readily and produce a dominant mass 
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X = OH 
Conv. [%]a 
X = NHAc 
Conv. [%]a 
Gal OH OH OH OH 76 13 
Gal2D H OH OH OH n.c. n.c. 
Gal3D OH H OH OH n.c. n.c. 
Gal4D OH OH H OH n.c. n.c. 
Gal6D OH OH OH H 65 9 
Gal2F F OH OH OH n.c. n.c. 
Gal3F OH F OH OH n.c. n.c. 
Gal4F OH OH F OH n.c. n.c. 
Gal6F OH OH OH F 41 1 
GalN NH2 OH OH OH 24 1 
       
a Determined by MALDI-ToF analysis (n.c. = not converted). 
 
spectrometry signal. This allows for relative quantitative studies 
by MALDI analysis, by integrating the isotopic envelope peak 
area of starting substrate and product.30–33  
According to the results obtained by MALDI-ToF (Table 1), 
NwLgtC could perform α1,4-galactosylation on both Lac-ITag 
and LacNAc-ITag using not only galactose, but also 6-
deoxygalactose, 6-fluorogalactose and galactosamine (ESI, 
Figures S13-S20). It is apparent that Lac-ITag acts as a much 
better acceptor than LacNAc-ITag, giving consistently higher 
conversion rates (Table 1). Additionally, it was found that Gal2D 
cannot be transferred by NwLgtC, in contrast with the reported 
behaviour of NmLgtC.23 The lower conversions obtained for 
non-natural donors are very likely due to the decreased 
efficiency of LgtC in transferring those, rather than the poor 
conversion of the monosaccharide to the UDP-donor. The 
efficiency of the one-pot UDP-sugar synthesis was previously 
established, and also confirmed by HRMS. 
The fact that NwLgtC accepts UDP-GalN as a donor is of 
particular relevance since previous reports demonstrated the 
inability of other homologues (e.g. NmLgtC) to transfer GalN3, a 
possible precursor of GalN. Thus, the use of NwLgtC opens up 
the access to galactosamine-containing Gb3 analogues. 
 
Preparative scale synthesis of Gal6D-α1,4-Lac-β-pNP 
In order to demonstrate the applicability of the enzyme 
described herein to preparative synthesis, an extended version 
of the same three-step multienzyme system discussed above 
was employed to synthesise a non-natural analogue of Gb3 





Scheme 1. One-pot preparative scale synthesis of Gal6D-α1,4-Lac-β-pNP using NwLgtC. 
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pNP-β-Lac as acceptor, the trisaccharide Gal6D-α1,4-Lac-β-pNP 
could be obtained in 50% conversion (as measured by HPLC), 
based on the acceptor. After the synthesis, the excess starting 
material Lac-β-pNP was removed by adding β-galactosidase and 
β-glucosidase. The pNP-trisaccharide was then separated from 
other monosaccharides and p-nitrophenol by preparative HPLC. 
Fractions containing product were collected and dried, 
affording 1.8 mg product (25% isolated yield, corrected for a 
small amount of an impurity that coeluted with the product). 
The structure of the compound was confirmed by NMR and 
HRMS characterisation (see ESI). 
Experimental section 
Materials  
Galactose, galactosamine, pNP-β-lactose, ATP, UTP, UDP-
galactose, UDP-glucose, UDP-N-acetylgalactosamine, UDP-N-
acetylglucosamine, UDP-glucuronic acid, 2,4,6-
trihydroxyacetophenone (THAP), β-galactosidase and inorganic 
pyrophosphatase were purchased from Sigma-Aldrich. 2-
deoxygalactose, 3-deoxygalactose, 4-deoxygalactose, 6-
deoxygalactose, 2-deoxy-2-fluorogalactose, 3-deoxy-3-
fluorogalactose, 4-deoxy-4-fluorogalactose, 6-deoxy-6-
fluorogalactose were purchased from Carbosynth. β-
glucosidase was purchased from Megazyme. Alkaline 
phosphatase was purchased from Promega. All chemicals and 
commercially available enzymes were used without any further 
purification. Galactokinase from Streptococcus pneumoniae 
(SpGalK), galactose-1-phosphate uridylyltransferase from E. coli 
K12 (EcGalPU) and β1,4-galactosyltransferase from N. 
meningitidis (NmLgtB-A) 29 were provided by Prozomix Ltd. The 
plasmid harbouring UDP-sugar pyrophosphorylase from 
Bifidobacterium longum (BlUSP) was provided by Prof. Josef 
Voglmeir (Nanjing Agricultural University, China). 
Protein expression and purification 
The gene of NwLgtC was synthesised by Twist Bioscience (San 
Francisco, USA) codon-optimised for E. coli expression. The 
synthesised DNA fragment was subcloned into plasmid pET28a, 
which was subsequently transformed into E. coli Top10 
competent cells. A few colonies bearing the construct were 
confirmed by plasmid DNA isolation and gene sequencing. The 
pET28a-NwLgtC construct was transformed into E. coli 
BL21(DE3) competent cells. Small-scale expression was carried 
out to determine the production of soluble and active protein. 
The large-scale expression was performed by inoculating 400 
mL autoinduction Terrific Broth medium in a 1 L flask and 
growing the culture at 25°C for 24 h (final OD600 between 10 and 
20). The cells were harvested by centrifugation (6000 g, 15 min, 
4°C), resuspended in HEPES buffer containing NaCl (500 mM) 
and imidazole (10 mM), and lysed by sonication. The cell debris 
and intact cells were removed by centrifugation (8000 g, 30 
min, 4°C). The protein was purified by immobilised metal 
affinity chromatography (IMAC) on a Ni2+-NTA column (GE 
Healthcare). The lysate was filtered through a 0.45 μm syringe 
filter and loaded on the column. Two wash steps were 
performed using the same buffer containing 10 mM and 50 mM 
imidazole, respectively. Then, the bound protein was eluted 
using the same buffer containing 500 mM imidazole. The 
fractions containing purified protein were combined and 
concentrated in a centrifugal filter. Protein precipitation was 
induced by addition of solid ammonium sulfate (to a final 
concentration of 3.2 M) and the resulting milky white 
suspension was stored at 4°Ϲ until use.  
Amino acid sequence of NwLgtC  
α1,4 galactosyltransferase cloned from Neisseria weaveri LMG 









Biochemical characterisation of NwLgtC 
Effect of temperature. A 50 µL reaction mixture containing pNP-
β-Lac (1 mM), UDP-Gal (2 mM), MnCl2 (10 mM), Tris buffer (50 
mM, pH 7.5) and NwLgtC (23 µg) was incubated at varying 
temperatures (6-80°C) for 1 h. The reaction was quenched by 
heating at 95°Ϲ for 5 min, followed by cooling on ice. The 
starting material pNP-β-Lac was hydrolysed by β-galactosidase 
and the product was analysed by HPLC. All assays were 
performed in triplicates.   
Effect of pH. A 50 µL reaction mixture containing pNP-β-Lac (1 
mM), UDP-Gal (2 mM), MnCl2 (10 mM) and NwLgtC (23 µg) in 
different buffers (50 mM, pH 4.0-9.0) at 37 °Ϲ for 1 h. Quenching 
and analysis were carried out as described above. All assays 
were performed in triplicates.  
Effect of divalent metal ions. A 50 µL reaction mixture 
containing pNP-β-Lac (1 mM), UDP-Gal (2 mM), Tris buffer (50 
mM, pH 7.5) and NwLgtC (23 µg) with different divalent metal 
ions (10 mM, Ca2+, Co2+, Cu2+, Mg2+, Mn2+, Ni2+ and Zn2+) or EDTA 
(10 mM) at 37 °Ϲ for 1 h. Quenching and analysis were carried 
out as described above. All assays were performed in triplicates. 
Determination of kinetic parameters of NwLgtC 
Several 50 µL reaction mixtures in Tris buffer (50mM, pH 7.5) 
were prepared, containing either different concentrations of 
the donor substrate UDP-Gal (i.e., 0.1, 0.3, 0.5, 0.7, 1, 2 mM) 
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with a fixed concentration of pNP-β-Lac (2 mM), or different 
concentrations of pNP-β-Lac (i.e., 0.3, 0.5, 1, 2, 4, 6, 8 and 10 
mM) with a fixed concentration of UDP-Gal (2 mM). The 
reactions were started by addition of NwLgtC (23 µg) and 
incubated at 37°Ϲ for 1 h. The reactions were quenched by 
heating at 95°Ϲ for 5 min, followed by cooling on ice. 
Subsequently, unreacted pNP-β-Lac was hydrolysed by 
incubation with β-glucosidase and β-galactosidase. The kinetic 
parameters were obtained by fitting the data to the Michaelis-
Menten equation using GraphPad Prism 7.03.  
Donor substrate specificity study  
Commercial nucleotide sugars as donors. A 20 µL reaction 
mixture containing lactose (1 mM), UDP-sugar (1.5 mM, Gal, 
Glc, GalNAc, GlcNAc, GlcA), Tris buffer (50 mM, pH 7.5), MnCl2 
(10 mM) and NwLgtC (7 µg) was incubated at 37°Ϲ overnight. 
The mixture was analysed by MALDI-ToF (positive mode) using 
THAP as matrix. 
Nucleotide sugars generated enzymatically in situ as donor: A 
40 µL reaction mixture containing different monosaccharides (8 
mM), ATP (10 mM), Tris buffer (50 mM, pH 8.0), MgCl2 (10 mM), 
SpGalK (12 µg), UTP (10 mM), BIUSP (3 µg), EcGalPU (1.3 µg) and 
pyrophosphatase (2 U) was incubated at 37°Ϲ overnight to 
synthesise the UDP-sugars. ITag-Lac and ITag-LacNAc (0.5 mM) 
were synthesised by using the recombinant bacterial β1,4 
galactosyltransferase NmLgtB-A according to published 
protocol.[29] Subsequently, a 10 µL reaction mixture consisting 
of ITag-Lac or ITag-LacNAc (0.1 mM), UDP-sugars, MnCl2 (10 
mM), Tris buffer (50 mM, pH 7.5) and NwLgtC (30 µg) was 
incubated at 37°Ϲ overnight. The mixture was analysed by 
MALDI-ToF (positive mode) using THAP as matrix. The 
conversion rate was calculated by integrating the isotopic 
envelope peak areas. 
Preparative scale synthesis of Gal6D-α1,4-Lac-β-pNP 
A one-pot three-step telescopic reaction was utilised to prepare 
Gal6D-α1,4-Lac-β-pNP. For the first step (phosphorylation of 
Gal6D) in a 50 mL Falcon tube a 5 mL reaction mixture was 
prepared, containing Gal6D (17 mg), ATP (85 mg), MgCl2 (10 
mM), MnCl2 (10 mM), Tris buffer (50 mM, pH 8.0) and SpGalK (8 
mg). The pH was immediately readjusted to 8.0 by addition of 
aq. NaOH (5 M), then the solution was incubated at 37°Ϲ 
overnight with gentle shaking. For the second step (UDP-Gal6D 
formation), 3 mL of a mixture containing UTP (110 mg), Tris 
buffer (pH 8.0, 50 mM), UDP-Glc (2 mM), BlUSP (3 mg), EcGalPU 
(1 mg) and pyrophosphatase (30 U) was added to the Falcon 
tube. The pH was immediately readjusted to 8.0 by addition of 
aq. NaOH (5 M), then the solution was incubated at 37°Ϲ 
overnight with gentle shaking. For the last step (α1,4 
galactosylation with UDP-Gal6D), pNP-β-Lac (5 mg, 10.8 μmol), 
NwLgtC (22 mg) and alkaline phosphatase (250 U) were added 
to the Falcon tube, and the solution was incubated at 37°Ϲ with 
gentle shaking. The reaction was monitored by HPLC until no 
more improvements in conversion could be seen. Then, β-
glucosidase and β-galactosidase were added to hydrolyse the 
excess starting material pNP-β-Lac giving Gal, Glc and pNP. The 
product Gal6D-α1,4-Lac-β-pNP was purified by preparative 
HPLC, and characterised by NMR and HRMS. White solid, 1.8 
mg, 27.4% isolated yield (including ~10% of an unidentified 
glycerol derivative that coeluted with the product), 25% 
corrected isolated yield (not taking into account the impurity 
present). 1H NMR (500 MHz, D2O): δ 8.21-8.17 (m, 2H, ArH), 
7.19-7.15 (m, 2H, ArH), 5.22 (d, J = 7.8 Hz, 1H, H-a1), 4.78 (d, J = 
4.1 Hz, 1H, H-c1), 4.46 (d, J = 7.7 Hz, 1H, H-b1), 4.40 (qd, J = 6.7, 
0.9 Hz, 1H, H-c5), 3.96-3.92 (m, 1H, H-a6’), 3.90 (d, J = 3.4 Hz, 
1H, H-b4), 3.88-3.79 (m, 6H, H-a6’’, H-b5, H-b6’, H-b6’’, H-c2, H-
c4), 3.79-3.66 (m, 5H, H-a3, H-a4, H-a5, H-b3, H-c3), 3.63-3.58 
(m, 1H, H-a2), dd (dd, J = 10.3, 7.9 Hz, H-b2), 1.09 (d, J = 6.6 Hz, 
3H, H-c6). 13C NMR (125 MHz, D2O): δ 161.6 (Ar Cquat), 142.6 
(Ar Cquat), 126.1 (Ar CH), 116.4 (Ar CH), 103.3 (C-b1), 100.1 (C-
c1), 99.2 (C-a1), 78.1 (C-a4), 76.9 (C-b4), 75.5 (C-a5 or C-b5), 
75.1 (C-a5 or C-b5), 74.1 (C-a3), 72.5 (C-a2), 72.0 (C-b2 or C-b3), 
71.9 (C-c4), 71.8 (C-b2 or C-b3), 69.3 (C-c2), 68.3 (C-c3), 67.1 (C-
c5), 60.2 (C-b6), 59.7 (C-a6), 15.2 (C-c6). HRMS (ESI): m/z for 
[M+Na]+ C24H35NNaO17+ calcd. 632.1797, found 632.1802; 
[M+K]+ C24H35KNO17+ calcd. 648.1537, found 648.1546. 
Conclusions 
In summary, a novel bacterial α1,4 galactosyltransferase from 
N. weaveri was produced and characterised. The optimal pH 
and temperature were established (7.5 and 40°Ϲ) and the 
highest enzymatic activity was achieved in the presence of 
Mn2+. A kinetic study to establish the catalytic efficiency of the 
enzyme against UDP-Gal and pNP-β-Lac was carried out. The 
donor substrate scope of the enzyme was investigated using 
commercial and in situ synthesised donors, revealing that UDP-
Gal, UDP-Gal6D, UDP-Gal6F and UDP-GalN as suitable donor 
substrates. Among them, to the best of our knowledge, Gal6F 
and GalN have never been reported as substrates for wild-type 
α1,4 galactosyltransferases. The transfer of GalN is interesting 
because the amine group has the potential for orthogonal 
conjugation and further derivatisation (and because the 
possible precursor GalN3 was previously shown not to be 
accepted by LgtC homologues). Furthermore, preparative scale 
synthesis of Gal6D-α1,4-Lac-β-pNP was executed, giving 25% 
overall yield. Consequently, the current study provides a 
valuable addition to the array of biocatalysts for glycobiology, 
in particular for the synthesis of modified α1,4-galactosides to 
be employed as probes and/or building blocks to study a range 
of infectious diseases. 
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